IRIS ACQUISITION CORP (IRAA)

US89601Y1010 - Common Stock

10.38  -0.25 (-2.35%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

IRIS ACQUISITION CORP

NASDAQ:IRAA (4/25/2024, 7:00:03 PM)

10.38

-0.25 (-2.35%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap74.63M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

IRAA Daily chart

Company Profile

Iris Acquisition Corp. operates as a blank check company. The company is headquartered in George Town, Grand Cayman. The company went IPO on 2021-03-09. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm is not engaged in any business nor generates any revenues.

Company Info

IRIS ACQUISITION CORP

3rd Floor Zephyr House,, 122 Mary Street, Po Box 10085

GEORGE TOWN GRAND CAYMAN

P: 13239927676

Employees: 0

IRAA News

News Image5 months ago - IssueWireIRIS ACQUISITION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

IRIS ACQUISITION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - IssueWire

News Imagea year ago - Market News VideoIRAA Makes Notable Cross Below Critical Moving Average
News Imagea year ago - GenScript ProBioProgram CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp

/PRNewswire/ -- Recently, Liminatus Pharma LLC ("Liminatus"), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies...

News Imagea year ago - Seeking AlphaIris Acquisition to combine with Liminatus Pharma (NASDAQ:IRAA)

Liminatus Pharma LLC and Iris Acquisition (IRAA) have entered into a definitive business combination pact

News Imagea year ago - Liminatus Pharma LLCLiminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments

IRAA Twits

Here you can normally see the latest stock twits on IRAA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example